Overall, it is a well‐planned and refined study that comprehensively demonstrated TMEM25 as a tumor suppressor protein that prevents the interaction of monomeric EGFR with STAT3 and thereby suppresses STAT3 phosphorylation and tumor progression (Figure 1B,C). The gene discussed is STAT3; the disease is neoplasm.